|
|
| Year : 2006 | Volume
: 50
| Issue : 1 | Page : 43-4 |
|
|
Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
S Chakrabarti, P Pradhan, A Roy, M Hira, G Bandyopadhyay, DK Bhattacharya
Dept. of Pathology, NRS Medical College
Correspondence Address:
S Chakrabarti
Dept. of Pathology, NRS Medical College
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 17193761 
|
|
|
Along with hepatitis B virus (HBV) and human immunodeficiency virus (HIV), Hepatitis C virus (HCV) is emerging as a major transfusion hazard. 22 cases of haemophilia (A 19, B 3) and 20 cases of thalassaemia (2 16, E(2) 4) constituted the study group. Patients tested for anti HCV (using third generation ELISA), HBsAg and antibodies to HIV I and II. Prevalence of anti HCV was 54.5% in haemophilics and 5% in thalassaemics. HBsAg was detected in 9.09% haemophilics and 5% thalassaemics. No anti HIV was detected in this cohort. Anti HCV seropositivity in haemophilics has increased compare to previous studies. |
|
|
|
| [PDF Not available]* |
|
 |
|
